TSX Penny Stocks To Watch: Cannabix Technologies And Two More

In This Article:

As Canadian markets navigate a landscape of conflicting forces, including persistent inflation and evolving leadership in various sectors, investors are keenly observing opportunities that might arise. Penny stocks, despite their somewhat outdated label, remain an intriguing segment for those seeking potential growth and value. These smaller or newer companies can offer unique investment opportunities when backed by strong financials, making them worthy of attention for those willing to explore beyond the mainstream market.

Top 10 Penny Stocks In Canada

Name

Share Price

Market Cap

Financial Health Rating

Alvopetro Energy (TSXV:ALV)

CA$4.84

CA$179.87M

★★★★★★

Mandalay Resources (TSX:MND)

CA$4.71

CA$442.31M

★★★★★★

Findev (TSXV:FDI)

CA$0.52

CA$14.32M

★★★★★★

PetroTal (TSX:TAL)

CA$0.70

CA$638.07M

★★★★★★

NamSys (TSXV:CTZ)

CA$1.13

CA$31.16M

★★★★★★

East West Petroleum (TSXV:EW)

CA$0.045

CA$4.07M

★★★★★★

Orezone Gold (TSX:ORE)

CA$0.90

CA$416.12M

★★★★★☆

Copper Road Resources (TSXV:CRD)

CA$0.015

CA$975.24k

★★★★★★

Hemisphere Energy (TSXV:HME)

CA$1.89

CA$177.67M

★★★★★☆

DIRTT Environmental Solutions (TSX:DRT)

CA$1.15

CA$224.35M

★★★★☆☆

Click here to see the full list of 935 stocks from our TSX Penny Stocks screener.

Below we spotlight a couple of our favorites from our exclusive screener.

Cannabix Technologies

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Cannabix Technologies Inc. is a technology company that develops marijuana and alcohol breathalyzers for employers, law enforcement, workplaces, and laboratories in the United States, with a market cap of CA$57.57 million.

Operations: Cannabix Technologies Inc. currently does not report any revenue segments.

Market Cap: CA$57.57M

Cannabix Technologies Inc., with a market cap of CA$57.57 million, remains pre-revenue, focusing on advancing its marijuana and alcohol breathalyzer technologies. Recent updates to the Cannabix Marijuana Breathalyzer aim to meet emerging regulatory requirements, enhancing features like ergonomic design and dual sample collection capabilities. The company also achieved a significant milestone with its Breath Logix device receiving positive certification from CEcert GmbH, paving the way for marketing in Australia and other regions. Despite ongoing losses, Cannabix maintains a stable cash runway exceeding one year without long-term liabilities or debt concerns.

CNSX:BLO Financial Position Analysis as at Feb 2025
CNSX:BLO Financial Position Analysis as at Feb 2025

First Lithium Minerals

Simply Wall St Financial Health Rating: ★★★★★☆